Recombinant Scorpine Produced Using SUMO Fusion Partner in Escherichia coli Has the Activities against Clinically Isolated Bacteria and Inhibits the Plasmodium falciparum Parasitemia In Vitro
Table 1
Minimum inhibitory concentrations of selected antibiotics against S. aureus and A. baumannii.